Men make use of their illnesses at least as much as they are made use of by them. - Aldous Huxley

Drugs > Tysabri (Natalizumab)

You are currently researching Natalizumab, below you will find the latest information on the subject of Natalizumab available at Drug Topics. Natalizumab is categorized in the N index of drugs (by medical name) and in T index of drugs (by common name).

The medical name for this drug is Natalizumab and the common name is Tysabri.

Natalizumab (Tysabri) News, Updated Regularly

Drug and health care stocks: The right prescription for 2009 - Bloggingstocks.com
January 5, 2009, 3:26 pm

Filed under: Pfizer (PFE) , Newsletters , Johnson and Johnson (JNJ) , Bristol-Myers Squibb (BMY) , Stocks to Buy , Best Stocks for 2009 Health care has long been considered a recession-resistant business. Given the current economic challenges, it's ...

Biotechnology News - Yahoo News
January 2, 2009, 5:42 am

THURSDAY, Jan. 1 (HealthDay News) -- In a finding that could help doctors fine-tune breast cancer treatments even further, a new study confirms that there are genes that increase the likelihood that the disease will spread throughout a woman's body ...

Barron's Profile: View From The Top - CattleNetwork.com
January 3, 2009, 6:10 am

Many fund managers describe themselves as "bottom-up" stockpickers, meaning they look for undervalued securities with growth potential, regardless of what the economy or market is doing. Jerry Jordan, who runs the Jordan Opportunity Fund (ticker ...

Indexes Post Apparent Distribution Day; Energy, Shipping & Fertilizers ... - Investors Business Daily
January 5, 2009, 2:21 pm

Pressure on the current rally increased as the major indexes appeared to chalk up a distribution day. The NYSE and Nasdaq composites, the Dow and the S&P 500 all clocked losses between 0.1% and 0.9%. Preliminary data showed all indexes closing at ...

Indexes In Holding Pattern; Volume Eases From Highs - Investors Business Daily
January 5, 2009, 10:18 am

Trading eased slightly and indexes stuck with mild losses in early afternoon action. The Dow backed off to a 0.9% loss. Citigroup ( C ) and American Express ( AXP ) turned in the Dow's strongest gains. Verizon Communications ( VZ ) and JPMorgan Chase ...

Biotech proves defensive against tough 2008 market - San Francisco Gate
December 31, 2008, 6:28 am

Sharp gains in shares of biotechnology heavyweights mitigated the wider sector's decline in 2008. Biotech stocks proved to be one of the safest investments this year, as strong drug sales and the potential for large buyout deals defended the sector ...

Are you looking for additional Tysabri (Natalizumab) news? Try our new "Natalizumab News Focus" area.

Are you looking for additional Tysabri (Natalizumab) information? Try our new "Natalizumab Related Blog Entries" area.

Off-site Natalizumab (Tysabri) Links, User Submitted

The following links have been collected through user bookmark submission in the Natalizumab_Tysabri category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Tue Jan 29

Fri Jan 18

Fri Nov 16

Thu Jun 7

Off-site Natalizumab Research Links

If you still need additional information on Natalizumab then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Drug Index

If you are researching a particular drug and know its common name use the alphabetical links below to quickly navigate to your desired subject.


If you are researching a particular drug and know its medical name use the alphabetical links below to quickly navigate to your desired subject.

Recommended Drug Sites

The following drug sites are listed in alphabetical order.

Recommended Health Sites

The following health sites are listed in alphabetical order.

Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Drug-Topics.org was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.


Powered by Odin Assemble 2.5a